Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ataxin 2-like pseudogene (ENSG00000224280, also known as LOC317727) is a genomic sequence that closely resembles the protein-coding Ataxin-2-like (ATXN2L) gene but does not encode a functional protein. Pseudogenes typically arise from gene duplication or retrotransposition events and lack the regulatory or coding capacity required for protein production. This pseudogene does not have an established biological function, is not associated with any human disease, and is not considered a therapeutic target. The functional ATXN2L gene (distinct from this pseudogene) participates in RNA metabolism and stress granule regulation[4]. However, ENSG00000224280 itself is non-functional and should not be confused with ATXN2L[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ataxin 2-like pseudogene.